spacer
 
spacer  
spacer
RSS
spacer spacer
spacerLogin | Subscribe | Free trial | Free reports
spacer  Agrow services
2
Subscribe to Agrow newsletter
  Issue 557
  > Contents
  > At a glance
  > Subscribe
1
Free trial
3
Click here for more details
 January 2009
  > Contents
  > Subscribe
3
spacer Agrow World Crop Protection News
spacer Agrow Magazine
spacer Agrow Intelligence
spacer Plant Biotech Projects
spacer Agrow Reports
spacer Agrow Awards
 
spacerInterview

Navigating the off-patent competitive landscape
By Sanjiv Rana, Editor
Agrow World Crop Protection News
Thursday, 6 October 2008

Dr Nigel Uttley: "It takes, on average, eight to ten years from discovery to registration for an agrochemical product, during which time, some 50,000 products will have been screened and discarded for the one that achieves commercial launch."

The managing director of UK-based Enigma Marketing Research, Dr Nigel Uttley, talks to Sanjiv Rana about the strategies for competing in the off-patent agrochemical market.

After a period of stagnation and even contraction, the global agrochemical market at around $35,000 million
rebounded last year to grow at close to 10%. Logically, the potentially larger pie in the years to come should result in rosy prospects for all players in the sector.

Dr Nigel Uttley feels that it all depends on which part of the pie a company operates in. He divides the agrochemical industry into three broad sectors:

1. Proprietary products with an enforceable patent, accounting for around 30% of the market.

Yes, give me a free trial

in print and online in PDF and online
Name:
Surname:
Job Title:
Company:
Address:
City:
Country:
Post/Zip Code:
Tel:
Email:
 
Privacy Policy
2. Off-patent proprietary products, where the active ingredient is offpatent but the final formulated
product: has some proprietary technology (such as a new delivery system, surfactant or safener); is linked to GM crops (such as Monsanto’s Roundup Ready crops); is a mixture product containing a patented active
ingredient; or has data protection issues that prevent generic manufacturers entering the
market. These products account for the bulk of the market at 42.5%.

3. Generic products, accounting for 27.5% of the market.

Dr Uttley says that the market share of proprietary products has declined over the years....


> Login for the full story
> Not a subscriber? Subscribe

RELATED NEWS

Rotam places generics in new dimension
New Generics: No pain, no gain?

 

 

 

Back to the top

 
    Login
Agrow's Service Company Guide 2008
spacer.gif

spacer

About Us  |  Privacy  |  Terms & Conditions | Advertise  |  Links  |  Contact
Informa Healthcare© 2008 Informa plc. All rights Reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36